Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Harvard Business School
Teva
US Department of Justice
Moodys
Argus Health
Fish and Richardson
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

PROTOPAM CHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Protopam Chloride patents expire, and what generic alternatives are available?

Protopam Chloride is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs.

The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pralidoxime chloride profile page.
Drug patent expirations by year for PROTOPAM CHLORIDE
Pharmacology for PROTOPAM CHLORIDE
Synonyms for PROTOPAM CHLORIDE
(hydroxyimino)(1-methyl(2-pyridyl))methane, chloride
[(E)-(1-methyl-2-pyridylidene)methyl]-oxo-ammonium chloride
[(E)-(1-methylpyridin-2-ylidene)methyl]-oxoazanium chloride
1-Methyl-2-aldoximinopyridinium chloride
1-Methyl-2-formylpyridinium chloride oxime
1-Methyl-2-pyridinium aldoxime chloride
1-Methylpyridinium-2-aldoxime Chloride
2-(Hydroxyiminomethyl)-1-methylpyridinium chloride
2-[(1E)-(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride
2-[(E)-(hydroxyimino)methyl]-1-methylpyridinium chloride
2-Formyl-1-methylpyridinium chloride oxime
2-Formyl-N-methylpyridinium oxime chloride
2-Hydroxyiminomethyl-1-methylpyridinium chloride
2-PAM
2-PAM (chloride)
2-PAM chloride
2-Pyridine aldoxime methyl chloride
2-Pyridine-aldoxime chloride
2-Pyridinealdoxime methochloride
2-Pyridinealdoximemethochloride
38X7XS076H
51-15-0
AC1NSDWQ
AC1Q1RUT
AKOS001094374
AKOS015892104
AKOS016339594
AN-41590
C7H9N2O.HCl
CAS-51-15-0
CCG-220943
CHEBI:8355
ComboPen
D00469
D0X7NU
DSSTox_CID_3495
DSSTox_GSID_23495
DSSTox_RID_77053
DTXSID1023495
EINECS 200-080-9
EN300-50184
HE009657
HE116016
HMS1570N08
HMS2097N08
HMS2232F12
HMS3259I04
I02-2928
J10435
KS-5324
LS-132536
M-2760
M0819
MFCD00011981
MLS000028727
MLS001076535
MLS002222315
MLS003876809
MolPort-004-440-359
N-Methylpyridine-2-aldoxime chloride
N-Methylpyridinium chloride 2-aldoxime
N-Methylpyridinium-2-aldoxime chloride
N-Metylpyridinium-2-aldoxime chloride
NCGC00016226-01
NCGC00178286-05
NSC 164614
NSC-164614
NSC164614
Opera_ID_228
Pam 2Cl
Pralidoximchlorid
pralidoxime
Pralidoxime (INN)
PRALIDOXIME CHLORIDE
Pralidoxime chloride (USP)
Pralidoxime chloride [USAN]
Pralidoxime chloride, United States Pharmacopeia (USP) Reference Standard
Pralidoximechloride
Pralidoxine chloride
Protopam
Protopam (TN)
pyraloxime methylchloride
Pyridine-2-aldoxime methochloride
Pyridinium aldoxime methochloride
Pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, chloride
Pyridinium, 2-[(hydroxyimino)methyl]-1-methyl-, chloride (1:1)
Pyridinium, 2-formyl-1-methyl-, chloride, oxime
Pyridinium, chloride, oxime
Q-201609
s4575
SCHEMBL1650343
SCHEMBL61419
SMR000059189
SR-01000721910
SR-01000721910-3
ST50825032
Tox21_110316
Tox21_110316_1
U602
UNII-38X7XS076H
WLN: T6KJ A1 B1UNQ &G

US Patents and Regulatory Information for PROTOPAM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp PROTOPAM CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 014134-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PROTOPAM CHLORIDE pralidoxime chloride TABLET;ORAL 014122-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Army
Federal Trade Commission
Express Scripts
Cerilliant
Mallinckrodt
Medtronic
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.